Status:

WITHDRAWN

Unicompartmental Knee Arthroplasty (UKA) Versus Total Knee Arthroplasty (TKA) of Medial Osteoarthritis

Lead Sponsor:

Ottawa Hospital Research Institute

Conditions:

Osteoarthritis, Knee

Eligibility:

All Genders

50-80 years

Phase:

NA

Brief Summary

This study allows patients to take part of the decision making between a unicompartment knee (partial ) or a total Knee replacement . Using the measures of a decision aid questionnaire which explicitl...

Detailed Description

Osteoarthritis of the knee is an increasingly common problem for many Canadians aged 50 or greater. When conservative management fails, patients are often offered a type of knee replacement as treatme...

Eligibility Criteria

Inclusion

  • Inclusion criteria must and will be restricted to those patients who are generally considered candidates for UKA. Specific inclusion criteria will be restricted to patients:
  • Who report that most of their pain (greater than 75%) is located in the medial part of the knee on a regular basis.
  • With active range of motion from 10° of extension to 100° of flexion.
  • With an intact, competent, anterior cruciate ligament.
  • With overall limb alignment correctable to neutral, indicating a competent medial collateral ligament.
  • With radiographs showing primarily bone-on-bone disease in the medial compartment with minimal wear in both the lateral and patellofemoral compartments of the knee.
  • 50 to 80 years of age.
  • With a Body Mass Index (BMI) less than 40.
  • For the secondary outcome of motion analysis, only patients exhibiting the following characteristics will be suitable for assessment:
  • BMI of 35 or less
  • No other ipsilateral or contralateral lower limb joint disorders

Exclusion

  • Those with inflammatory arthritis
  • Those with no fixed address
  • Those unable to commit to study requirements and follow-ups

Key Trial Info

Start Date :

January 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2025

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT03457051

Start Date

January 1 2021

End Date

September 1 2025

Last Update

July 2 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Ottawa Hospital

Ottawa, Ontario, Canada, K1H 8L6